Is the cancer immunotherapy market up for disruption as AstraZeneca, Regeneron-Sanofi, cheaper Chinese offerings line up?
Is the cancer immunotherapy market up for disruption as AstraZeneca, [...]
U.S. appeals court sides with Catalyst, calling FDA approval of Jacobus’ Ruzurgi ‘arbitrary,’ ‘capricious’ and unlawful
U.S. appeals court sides with Catalyst, calling FDA approval of [...]
Fierce Pharma Asia—Biogen-Eisai’s Alzheimer’s drug filing; Samsung-Roche deal growth; Sunovion-Otsuka neuro pact
Fierce Pharma Asia—Biogen-Eisai’s Alzheimer’s drug filing; Samsung-Roche deal growth; Sunovion-Otsuka [...]
Insider trading on 2 M&A deals made former Goldman Sachs compliance officer more than $77K, SEC charges
Insider trading on 2 M&A deals made former Goldman Sachs [...]
Fujifilm completes construction of Netherlands production facility, enters validation stage
Fujifilm completes construction of Netherlands production facility, enters validation stage [...]
Mirum gets iBAT inhibitor Livmarli across the FDA finish line for rare pediatric liver condition
Mirum gets iBAT inhibitor Livmarli across the FDA finish line [...]
Despite rough start, Biogen’s Aduhelm should find footing, analysts say. But don’t expect much in 2021
Despite rough start, Biogen’s Aduhelm should find footing, analysts say. [...]
Samsung Biologics sees more than 10x growth in value of CMO deal with Roche
Samsung Biologics sees more than 10x growth in value of [...]
In Humira kickbacks case, disgruntled AbbVie investors score class-action status
In Humira kickbacks case, disgruntled AbbVie investors score class-action status [...]
Kyowa Kirin’s awareness message for physicians goes beyond skin-deep for Poteligeo rare cancer drug
Kyowa Kirin’s awareness message for physicians goes beyond skin-deep for [...]